It’s been a busy past few weeks. Last Tuesday, as many of you know, our External Scientific Advisory Committee (ESAC) visited and conducted a remarkably thorough and helpful review of the cancer center. My thanks go out to everyone who prepared so hard to make this a successful and productive exercise. We received generally positive feedback along with specific suggestions that will improve the clarity of our upcoming core grant submission. Several of the ESAC members joined a few of us at the Rutgers game and got to see the only game that Georgetown has won in recent memory. We must bring the ESAC back soon!
I also had the pleasant opportunity to meet with the Lombardi Gala Corporate Committee to continue our planning for this year’s Gala. I’m really excited about resuming this wonderful tradition after a one year hiatus.
This week was highlighted by the University Board of Director’s meeting. As always, I was pleased to note the incredibly thoughtful and wise perspective of our board. I really mean that! And I’m very happy to have their unwavering support for the Lombardi and its mission.
Yesterday’s activities were enlivened by a trip to the NIH campus where Minetta Liu and I met with Jay Berzofsky and his colleagues to discuss collaboration around a novel vaccine concept for the treatment of HER2 positive breast cancer. I think we’ll have a lot of fun working with Jay and his colleagues, and we’ll be able to offer our patients cutting-edge options as well. The visit exemplified for me the potential for reaching out to local governmental and non-governmental entities to collaborate in areas of high scientific importance. As they say in real estate – location, location, location!
Now it’s time to get back to writing my section of the core grant renewal. Talk to you next week.
Update: Be sure to check out the comments we received on the logos. Thank you for your very thoughtful responses. We are taking all of the feedback into consideration as we move forward in collaboration with the University on our branding initiative.